Xenetic Biosciences Inc (XBIO): What Makes The Stock Good?
Xenetic Biosciences Inc (NASDAQ:XBIO) has a beta value of 2.29 and has seen 1.63 million shares traded in the recent trading session. The company, currently
Xenetic Biosciences Inc (NASDAQ:XBIO) has a beta value of 2.29 and has seen 1.63 million shares traded in the recent trading session. The company, currently
X3 Holdings Co Ltd (NASDAQ:XTKG) has a beta value of 1.47 and has seen 0.8 million shares traded in the recent trading session. The company,
Centene Corp (NYSE:CNC) has a beta value of 0.45 and has seen 1.22 million shares traded in the recent trading session. The company, currently valued
Enbridge Inc (NYSE:ENB) has a beta value of 0.74 and has seen 1.11 million shares traded in the recent trading session. The company, currently valued
Campbells Co (NASDAQ:CPB) has a beta value of 0.10 and has seen 1.13 million shares traded in the recent trading session. The company, currently valued
Companhia Siderurgica Nacional ADR (NYSE:SID) has a beta value of 1.71 and has seen 1.56 million shares traded in the recent trading session. The company,
Adaptive Biotechnologies Corp (NASDAQ:ADPT) has a beta value of 1.80 and has seen 1.84 million shares traded in the recent trading session. The company, currently
BridgeBio Pharma Inc (NASDAQ:BBIO) has a beta value of 1.13 and has seen 1.19 million shares traded in the recent trading session. The company, currently
Suncor Energy, Inc (NYSE:SU) has a beta value of 0.82 and has seen 1.47 million shares traded in the recent trading session. The company, currently
Bumble Inc (NASDAQ:BMBL) has a beta value of 1.89 and has seen 5.98 million shares traded in the recent trading session. The company, currently valued
© 2024, Powered by Smart TechOne